Article
Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a.
The Journal of urology - 1 Dec 1999
Zhao X Y, Boyle B, Krishnan A V, Navone N M, Peehl D M, Feldman D
Abstract excerpt
PURPOSE: We have characterized the androgen receptor (AR) in a new human prostate cancer cell line, MDA PCa 2a, that has recently been established from a bone metastasis of a patient whose cancer exhibited androgen-independent growth. MATERIALS AND METHODS: Androgen responsiveness of these cells was assessed by measuring the effect of DHT and R1881 on cell growth and PSA secretion. Scatchard analysis was used to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
